KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $27.14 $33.02 Friday, 26th Apr 2024 AGIO stock ended at $31.49. This is 0.568% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.20% from a day low at $31.32 to a day high of $32.01.
90 days $22.23 $35.48
52 weeks $19.80 $35.48

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
Apr 26, 2024 $31.70 $32.01 $31.32 $31.49 407 162
Apr 25, 2024 $31.22 $32.25 $31.22 $31.67 696 889
Apr 24, 2024 $32.08 $32.26 $31.32 $31.67 544 486
Apr 23, 2024 $30.40 $33.02 $30.40 $31.81 1 224 626
Apr 22, 2024 $29.66 $30.89 $29.50 $30.21 823 640
Apr 19, 2024 $29.27 $30.26 $28.71 $29.53 747 364
Apr 18, 2024 $29.10 $29.90 $29.03 $29.43 549 245
Apr 17, 2024 $28.93 $29.34 $28.89 $29.03 461 842
Apr 16, 2024 $29.07 $29.59 $28.74 $28.80 449 768
Apr 15, 2024 $29.78 $29.80 $28.73 $29.26 617 987
Apr 12, 2024 $30.50 $30.70 $28.71 $29.51 680 794
Apr 11, 2024 $30.40 $31.02 $29.90 $30.63 801 382
Apr 10, 2024 $29.23 $30.26 $29.05 $29.94 723 924
Apr 09, 2024 $27.84 $29.86 $27.81 $29.71 941 579
Apr 08, 2024 $27.56 $28.39 $27.14 $27.70 548 972
Apr 05, 2024 $27.79 $28.24 $27.45 $27.55 550 054
Apr 04, 2024 $28.81 $28.86 $27.72 $27.92 390 492
Apr 03, 2024 $28.56 $28.73 $28.01 $28.47 514 742
Apr 02, 2024 $28.38 $28.99 $27.91 $28.67 544 164
Apr 01, 2024 $29.28 $29.37 $28.66 $28.86 401 480
Mar 28, 2024 $29.19 $29.42 $28.82 $29.24 407 496
Mar 27, 2024 $29.24 $29.42 $28.57 $29.12 647 397
Mar 26, 2024 $30.07 $30.23 $28.87 $29.06 554 730
Mar 25, 2024 $29.81 $30.21 $29.52 $29.68 413 837
Mar 22, 2024 $30.40 $30.66 $29.84 $29.88 442 146
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT